CTSO
Cytosorbents Crp
4.10$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.49 | 3.29 | 3.31 | 3.26 | 3.16 | 3.34 | 2.87 | 2.86 | 3.02 | 2.94 | 2.83 | 3.07 | 11.85 | |
| 1.44 | 1.05 | 0.78 | 0.86 | 1.51 | -0.09 | 0.83 | 0.83 | 0.90 | 0.77 | 0.87 | 0.82 | 3.36 | |
| 2.05 | 2.24 | 2.53 | 2.39 | 1.65 | 3.44 | 2.04 | 2.03 | 2.12 | 2.17 | 1.95 | 2.24 | 8.49 | |
| 1.69 | 1.83 | 0.83 | 0.56 | 0.68 | 0.47 | 0.55 | 0.38 | 0.29 | 0.40 | 0.33 | 0.46 | 1.48 | |
| 4.15 | 4.73 | 3.41 | 3.09 | 2.87 | 0.74 | 2.78 | 2.73 | 2.74 | 3.00 | 2.60 | 2.54 | 10.88 | |
| 5.36 | 6.56 | 4.25 | 3.71 | 3.27 | 4.91 | 3.32 | 3.11 | 3.04 | 3.40 | 2.92 | 3.08 | 12.44 | |
| -3.31 | -4.32 | -1.72 | -1.31 | -1.61 | -1.48 | -1.28 | -1.08 | -0.91 | -1.23 | -0.97 | -0.84 | -3.95 | |
| 0.02 | 0.02 | 0.00 | 0.07 | 0.22 | 0.23 | 0.20 | 0.18 | 0.21 | 0.24 | 0.27 | 0.28 | 0.99 | |
| -4.14 | -3.11 | -2.24 | -1.58 | -0.86 | -3.50 | -0.49 | 0.58 | -1.14 | -1.75 | -1.64 | -1.41 | -5.93 | |
| -0.19 | -0.36 | 0.00 | 0.00 | – | -0.62 | – | – | -0.13 | – | – | – | – | |
| -4.14 | -2.75 | -2.24 | -1.58 | -0.86 | -2.88 | -0.49 | 0.58 | -1.01 | -1.75 | -1.64 | -1.41 | -5.80 | |
| -3.92 | -2.73 | -2.08 | -1.35 | -0.48 | -3.12 | -0.15 | 0.89 | -0.80 | -1.39 | -1.24 | -1.07 | -4.50 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.